Literature DB >> 12009237

Intrabronchial orthotopic propagation of human lung adenocarcinoma--characterizations of tumorigenicity, invasion and metastasis.

Kentaro Mase1, Tatsuo Iijima, Naoko Nakamura, Tomoyo Takeuchi, Masataka Onizuka, Toshio Mitsui, Masayuki Noguchi.   

Abstract

Using the intrabronchial orthotopic propagation method, we evaluated the biological characteristics of human adenocarcinoma cell lines in vivo and examined the expressions of matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their related proteins. Nine human lung adenocarcinoma cell lines, including A549, NCI-H23, NCI-H322, NCI-H358, Calu-3, PC-14, LC-2/ad, RERF-LC-KJ and PL16T, were injected into the peripheral bronchi of mice using this method. The mice were sacrificed at 4 and 8 weeks after tumor cell propagation and the lungs and other organs were observed macroscopically and histologically. We classified the adenocarcinoma cell lines, according to their intrapulmonary tumorigenicity, into the following three groups: (A) those that showed a high incidence of intrapulmonary implantation (>50%) (A549 and NCI-H358). A549 showed mediastinal lymph node metastasis and pleural dissemination; (B) those that showed a low incidence of intrapulmonary implantation (PC-14, NCI-H322, NCI-H23, Calu-3, and LC-2/ad); (C) those that showed no tumorigenicity in the lung (RERF-LC-KJ and PL16T). In order to characterize the biological differences between each cell line, we investigated the expressions of MMP-2 and MMP-9 and their related molecules by northern blot analysis. The expressions of MMP-2 and MMP-9 and their activators (membrane-type 1-MMP and urokinase-type plasminogen activator) were thought to be associated with the growth, invasion and metastasis of the human lung adenocarcinoma cell lines examined.

Entities:  

Mesh:

Year:  2002        PMID: 12009237     DOI: 10.1016/s0169-5002(02)00004-1

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

1.  Transcription initiation activity of adenovirus left-end sequence in adenovirus vectors with e1 deleted.

Authors:  Masato Yamamoto; Julia Davydova; Koichi Takayama; Ramon Alemany; David T Curiel
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Establishment of a malignant pleural effusion mouse model with lewis lung carcinoma cell lines expressing enhanced green fluorescent protein.

Authors:  Xingqun Ma; Yu Sun; Shouju Wang; Zhijian Yang; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2012-09

3.  Mouse orthotopic lung cancer model induced by PC14PE6.

Authors:  Zheng Yun Cui; Jin Seok Ahn; Jee Yun Lee; Won Seog Kim; Ho Yeong Lim; Hyun Jung Jeon; Soo Won Suh; Jin Hoon Kim; Won Ho Kong; Ji Min Kang; Do Hyun Nam; Keunchil Park
Journal:  Cancer Res Treat       Date:  2006-12-31       Impact factor: 4.679

4.  Aerosolized BC-819 inhibits primary but not secondary lung cancer growth.

Authors:  Günther Hasenpusch; Corinna Pfeifer; Manish Kumar Aneja; Kai Wagner; Dietrich Reinhardt; Michal Gilon; Patricia Ohana; Avraham Hochberg; Carsten Rudolph
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

5.  [Establishment of a malignant pleural effusion mouse model with Lewis lung carcinoma cell lines expressing enhanced green fluorescent protein].

Authors:  Xingqun Ma; Yu Sun; Shouju Wang; Zhijian Yang; Yong Song
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-06

6.  Stratifin accelerates progression of lung adenocarcinoma at an early stage.

Authors:  Aya Shiba-Ishii; Yunjung Kim; Toshihiro Shiozawa; Shinji Iyama; Kaishi Satomi; Junko Kano; Shingo Sakashita; Yukio Morishita; Masayuki Noguchi
Journal:  Mol Cancer       Date:  2015-07-30       Impact factor: 27.401

7.  Transbronchial Dissemination of Squamous Cell Lung Cancer.

Authors:  Akira Tadokoro; Nobuhiro Kanaji; Tomoya Ishii; Naoki Watanabe; Takuya Inoue; Norimitsu Kadowaki; Shuji Bandoh
Journal:  Clin Med Insights Oncol       Date:  2015-12-08

8.  Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines.

Authors:  Angeliki Korpetinou; Dionysios J Papachristou; Angeliki Lampropoulou; Panagiotis Bouris; Vassiliki T Labropoulou; Argyrios Noulas; Nikos K Karamanos; Achilleas D Theocharis
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.